Moderna Rockets 13% to 2024 Highs as Healthcare Outperforms
Moderna surged nearly 13% after an investor event, driving a broader healthcare rally as investors rotated out of tech. The S&P 500 healthcare sector benefited from defensive positioning amid AI chip turmoil.